Cyclophosphamide is a highly effective and safe induction therapy in chronic periaortitis: A long-term follow-up of 35 patients with chronic periaortitis

Annals of the Rheumatic Diseases

Volumn 71, Issue 2, 2012, Pages 311-312

  Binder, M ^a   Uhl, M ^b   Wiech, T ^a   Kollert, F ^a   Thiel, J ^a   Sass, J O ^a   Walker, U A ^c   Peter, H H ^a   Warnatz, Klaus ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b RKK Freiburg ^*  (Germany)

^c Felix Platter Spital   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CD38 ANTIGEN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOGLOBULIN G4; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; LETTER; LEUKOPENIA; LOW DRUG DOSE; PERIAORTITIS; PRIORITY JOURNAL; RETROPERITONEUM; RETROSPECTIVE STUDY; SIDE EFFECT; UNSPECIFIED SIDE EFFECT;

CYCLOPHOSPHAMIDE; DRUG EVALUATION; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MAGNETIC RESONANCE IMAGING; RETROPERITONEAL FIBROSIS; SMOKING; TREATMENT OUTCOME;

EID: 84860396201     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2011-200148     Document Type: Letter

References (10)

1. Vaglio A, Salvarani C, Buzio C. Retroperitoneal fibrosis. Lancet 2006;367:241-51. (Pubitemid 43107670)
2. Palmisano A, Vaglio A. Chronic periaortitis: a fibro-inflammatory disorder. Best Pract Res Clin Rheumatol 2009;23:339-53.
3. Stone JR. Aortitis, periaortitis, and retroperitoneal fibrosis, as manifestations of IgG4-related systemic disease. Curr Opin Rheumatol 2011;23:88-94.
4. Marcolongo R, Tavolini IM, Laveder F, et al. Immunosuppressive therapy for idiopathic retroperitoneal fibrosis: a retrospective analysis of 26 cases. Am J Med 2004;116:194-7. (Pubitemid 38121678)
5. Warnatz K, Keskin AG, Uhl M, et al. Immunosuppressive treatment of chronic periaortitis: a retrospective study of 20 patients with chronic periaortitis and a review of the literature. Ann Rheum Dis 2005;64:828-33. (Pubitemid 40733903)
6. van Bommel EF, Hendriksz TR, Huiskes AW, et al. Brief communication: tamoxifen therapy for nonmalignant retroperitoneal fibrosis. Ann Intern Med 2006;144:101-6. (Pubitemid 46768228)
7. Vega J, Goecke H, Tapia H, et al. Treatment of idiopathic retroperitoneal fibrosis with colchicine and steroids: a case series. Am J Kidney Dis 2009;53:628-37.
8. Swartz RD. Idiopathic retroperitoneal fibrosis: a review of the pathogenesis and approaches to treatment. Am J Kidney Dis 2009;54:546-53.
9. Scheel PJ, Feeley N, Sozio SM. Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis: a case series. Ann Intern Med 2011;154:31-6.
10. Zen Y, Onodera M, Inoue D, et al. Retroperitoneal fibrosis: a clinicopathologic study with respect to immunoglobulin G4. Am J Surg Pathol 2009;33:1833-9.